These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38810528)

  • 1. Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancer.
    Ke H; Kao S; van Zandwijk N; Rasko JEJ; Yeo D
    Lung Cancer; 2024 Jun; 192():107829. PubMed ID: 38810528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer.
    Maly V; Maly O; Kolostova K; Bobek V
    In Vivo; 2019; 33(4):1027-1037. PubMed ID: 31280190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells in patients with lung cancer: developments and applications for precision medicine.
    Tong B; Wang M
    Future Oncol; 2019 Jul; 15(21):2531-2542. PubMed ID: 31339062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A very public death: dying of mesothelioma and asbestos-related lung cancer (M/ARLC) in the Latrobe Valley, Victoria, Australia.
    Lee SF; O'Connor MM; Chapman Y; Hamilton V; Francis K
    Rural Remote Health; 2009; 9(3):1183. PubMed ID: 19731971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer.
    Sinoquet L; Jacot W; Gauthier L; Pouderoux S; Viala M; Cayrefourcq L; Quantin X; Alix-Panabières C
    Clin Chem; 2021 Nov; 67(11):1503-1512. PubMed ID: 34355741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
    Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
    Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring.
    Li W; Liu JB; Hou LK; Yu F; Zhang J; Wu W; Tang XM; Sun F; Lu HM; Deng J; Bai J; Li J; Wu CY; Lin QL; Lv ZW; Wang GR; Jiang GX; Ma YS; Fu D
    Mol Cancer; 2022 Jan; 21(1):25. PubMed ID: 35057806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
    Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD
    Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
    Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
    Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy for lung cancer screening: Usefulness of circulating tumor cells and other circulating blood biomarkers.
    Hofman P
    Cancer Cytopathol; 2021 May; 129(5):341-346. PubMed ID: 33007153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asbestos-related lung cancer: Clinical characteristics and survival outcomes in an Australian cohort seeking workers compensation.
    Hyland RA; Chrzanowska A; Hannaford-Turner K; Davis A; Ke H; Bradbury L; Nagrial A; McCaughan B; Hui R; van Zandwijk N; Takahashi K; Kao SC
    Asia Pac J Clin Oncol; 2022 Oct; 18(5):e448-e455. PubMed ID: 35100476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
    Morrison GJ; Goldkorn A
    Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
    Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
    Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells in breast cancer: applications in personalized medicine.
    Lee JS; Magbanua MJM; Park JW
    Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells in precision medicine: challenges and opportunities.
    Rupp B; Ball H; Wuchu F; Nagrath D; Nagrath S
    Trends Pharmacol Sci; 2022 May; 43(5):378-391. PubMed ID: 35272862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer.
    Moon SM; Kim JH; Kim SK; Kim S; Kwon HJ; Bae JS; Lee S; Lee HS; Choi MY; Jeon BH; Jeong BH; Lee K; Kim HK; Kim J; Um SW
    Anticancer Res; 2020 Jun; 40(6):3435-3444. PubMed ID: 32487642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab.
    Guibert N; Delaunay M; Lusque A; Boubekeur N; Rouquette I; Clermont E; Mourlanette J; Gouin S; Dormoy I; Favre G; Mazieres J; Pradines A
    Lung Cancer; 2018 Jun; 120():108-112. PubMed ID: 29748004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal.
    Mentis AA; Grivas PD; Dardiotis E; Romas NA; Papavassiliou AG
    Cell Mol Life Sci; 2020 Sep; 77(18):3671-3690. PubMed ID: 32333084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer.
    Dong J; Zhu D; Tang X; Lu D; Qiu X; Li B; Lin D; Li L; Liu J; Zhou Q
    PLoS One; 2019; 14(7):e0220306. PubMed ID: 31348821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.